The Motley Fool

Down More Than 50%, Is DexCom Stock a Bargain Now?

Predictions of a sales-growth slowdown sent DexCom stock tumbling this summer. Management predicted third-quarter sales would rise by just 1% to 3% year over year. Two of DexCom's top competitors ...
The Motley Fool

Is DexCom a Good Healthcare Stock to Buy Now?

Shares of DexCom recently soared after the company reported better-than-expected third-quarter results. DexCom markets constant blood-glucose monitors for diabetic patients, and its next-generation ...
Healio

Endocrine Society issues guidance for CGM trend arrow data

Please provide your email address to receive an email when new articles are posted on . Researchers with the Endocrine Society developed two guidelines for pediatric and adult patients using the ...
Medscape

Advice for CGM Trend Arrow Data to Adjust Insulin Doses in Diabetes

The Endocrine Society has published new guidance for how to incorporate trend-arrow information from the Dexcom G5 continuous glucose monitoring (CGM) system into insulin dose adjustments for patients ...
Healthline

Dexcom and Garmin Enable CGM Data Viewing

For those in the diabetes community who’ve dreamed about seeing their in-the-moment blood sugar readings and trend data right on their smartwatch or bike computer while exercising, Dexcom and Garmin ...
Business Wire

Dexcom G6 Real-Time CGM System Now Available to All Clients With Type 1 Diabetes Covered Under the Non-Insured Health Benefits Program

Dexcom G6 was the first Continuous Glucose Monitoring (CGM) System to be officially listed by the NIHB Drug Benefit program. BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), ...